BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18593631)

  • 1. HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study.
    Pankow JS; Boerwinkle E; Adams PC; Guallar E; Leiendecker-Foster C; Rogowski J; Eckfeldt JH
    Transl Res; 2008 Jul; 152(1):3-10. PubMed ID: 18593631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of H63D homozygosity in a Basque population with hemochromatosis.
    Castiella A; Zapata E; de Juan MD; Otazua P; Fernandez J; Zubiaurre L; Arriola JA;
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1295-8. PubMed ID: 20594259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis.
    Allen KJ; Bertalli NA; Osborne NJ; Constantine CC; Delatycki MB; Nisselle AE; Nicoll AJ; Gertig DM; McLaren CE; Giles GG; Hopper JL; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC;
    Hepatology; 2010 Sep; 52(3):925-33. PubMed ID: 20583211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
    Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
    J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.
    Phatak PD; Ryan DH; Cappuccio J; Oakes D; Braggins C; Provenzano K; Eberly S; Sham RL
    Blood Cells Mol Dis; 2002; 29(1):41-7. PubMed ID: 12482402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.
    McLaren CE; Barton JC; Gordeuk VR; Wu L; Adams PC; Reboussin DM; Speechley M; Chang H; Acton RT; Harris EL; Ruggiero AM; Castro O;
    Am J Hematol; 2007 Oct; 82(10):898-905. PubMed ID: 17597476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.
    Adams PC; Speechley M; Barton JC; McLaren CE; McLaren GD; Eckfeldt JH
    Hepatology; 2012 Jun; 55(6):1722-6. PubMed ID: 22183642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening.
    McLaren GD; McLaren CE; Adams PC; Barton JC; Reboussin DM; Gordeuk VR; Acton RT; Harris EL; Speechley MR; Sholinsky P; Dawkins FW; Snively BM; Vogt TM; Eckfeldt JH;
    Can J Gastroenterol; 2008 Nov; 22(11):923-30. PubMed ID: 19018338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study.
    Rasmussen ML; Folsom AR; Catellier DJ; Tsai MY; Garg U; Eckfeldt JH
    Atherosclerosis; 2001 Feb; 154(3):739-46. PubMed ID: 11257277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study.
    Zaloumis SG; Allen KJ; Bertalli NA; Turkovic L; Delatycki MB; Nicoll AJ; McLaren CE; English DR; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC;
    J Gastroenterol Hepatol; 2015 Apr; 30(4):719-25. PubMed ID: 25311314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic alterations, HFE gene mutations and atherogenic lipoprotein modifications in patients with primary iron overload.
    Meroño T; Brites F; Dauteuille C; Lhomme M; Menafra M; Arteaga A; Castro M; Saez MS; Ballerga EG; Sorroche P; Rey J; Lesnik P; Sordá JA; Chapman MJ; Kontush A; Daruich J
    Clin Sci (Lond); 2015 May; 128(9):609-18. PubMed ID: 25442240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort.
    Pilling LC; Atkins JL; Melzer D
    Hepatology; 2022 Dec; 76(6):1735-1745. PubMed ID: 35567766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.
    Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM
    Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
    Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH
    Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy.
    Atkins JL; Pilling LC; Masoli JAH; Kuo CL; Shearman JD; Adams PC; Melzer D
    JAMA; 2020 Nov; 324(20):2048-2057. PubMed ID: 33231665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
    Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
    Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.